| # |
Drug Name |
Drug Class |
Main Use |
Key Nursing Consideration |
| 1 |
Metoprolol |
Beta-Blocker |
Hypertension, Angina, Heart failure |
Monitor HR & BP; do not abruptly stop; assess for bradycardia |
| 2 |
Lisinopril |
ACE Inhibitor |
Hypertension, Heart failure |
Monitor for dry cough, hyperkalemia, angioedema; check BMP |
| 3 |
Amlodipine |
Calcium Channel Blocker |
Hypertension, Angina |
Monitor BP; watch for peripheral edema and headache |
| 4 |
Furosemide (Lasix) |
Loop Diuretic |
Edema, Heart failure, HTN |
Monitor I&O, electrolytes (K+), weight daily; ototoxicity risk |
| 5 |
Digoxin |
Cardiac Glycoside |
Heart failure, Atrial fibrillation |
Monitor apical pulse (hold if <60); check digoxin levels; toxicity = N/V, yellow-green vision |
| 6 |
Warfarin (Coumadin) |
Anticoagulant (Vitamin K antagonist) |
DVT, PE, A-fib |
Monitor INR (therapeutic: 2–3); assess for bleeding; many food/drug interactions |
| 7 |
Heparin |
Anticoagulant |
DVT, PE, ACS |
Monitor aPTT (therapeutic: 60–100 s); antidote: Protamine sulfate; watch for HIT |
| 8 |
Aspirin |
Antiplatelet / NSAID |
ACS, TIA, pain, fever |
Monitor for GI bleeding, tinnitus; give with food; avoid in children (Reye syndrome) |
| 9 |
Atorvastatin |
HMG-CoA Reductase Inhibitor (Statin) |
Hyperlipidemia, CV prevention |
Monitor LFTs, CK; watch for myopathy; give at bedtime |
| 10 |
Nitroglycerin |
Nitrate / Vasodilator |
Angina pectoris |
SL: 3 doses q5 min; monitor BP; headache common; store in dark glass bottle |
| 11 |
Albuterol |
Short-Acting Beta-2 Agonist (SABA) |
Acute asthma, Bronchospasm |
Assess lung sounds; tachycardia possible; rescue inhaler — not preventive |
| 12 |
Fluticasone |
Inhaled Corticosteroid (ICS) |
Asthma maintenance, COPD |
Rinse mouth after use (thrush prevention); not for acute attacks |
| 13 |
Montelukast |
Leukotriene Receptor Antagonist |
Asthma, Allergic rhinitis |
Once daily at bedtime; monitor for mood changes, suicidal ideation |
| 14 |
Tiotropium |
Long-Acting Anticholinergic (LAMA) |
COPD maintenance |
Not for acute bronchospasm; monitor urinary retention, dry mouth |
| 15 |
Prednisone |
Systemic Corticosteroid |
Asthma exacerbation, Inflammation |
Give with food; taper dose; monitor blood glucose, weight, BP; immunosuppressant |
| 16 |
Morphine |
Opioid Analgesic |
Severe pain, Pulmonary edema |
Monitor RR (hold if <12); antidote: Naloxone; assess sedation; prevent constipation |
| 17 |
Tramadol |
Opioid-like Analgesic |
Moderate to severe pain |
Lowers seizure threshold; serotonin syndrome risk; monitor CNS depression |
| 18 |
Acetaminophen |
Analgesic / Antipyretic |
Pain, Fever |
Max 4g/day; hepatotoxicity with overdose; antidote: N-acetylcysteine |
| 19 |
Ibuprofen |
NSAID |
Pain, Fever, Inflammation |
Take with food; monitor renal function & GI bleeding; avoid in renal impairment |
| 20 |
Phenytoin |
Anticonvulsant (Hydantoin) |
Seizures, Arrhythmias |
Monitor phenytoin levels (10–20 mcg/mL); gingival hyperplasia; IV: monitor ECG |
| 21 |
Valproic Acid |
Anticonvulsant / Mood stabilizer |
Seizures, Bipolar disorder |
Monitor LFTs & ammonia; teratogenic; check valproate levels (50–100 mcg/mL) |
| 22 |
Levetiracetam |
Anticonvulsant |
Partial & generalized seizures |
Monitor for behavioral changes; minimal drug interactions; renal dosing required |
| 23 |
Haloperidol |
Typical Antipsychotic |
Schizophrenia, Acute agitation |
Monitor for EPS (akathisia, dystonia); QTc prolongation; NMS risk |
| 24 |
Olanzapine |
Atypical Antipsychotic |
Schizophrenia, Bipolar disorder |
Monitor metabolic syndrome (weight, blood glucose, lipids); sedation |
| 25 |
Sertraline (Zoloft) |
SSRI Antidepressant |
Depression, Anxiety, OCD, PTSD |
Monitor for serotonin syndrome; 4–6 weeks for full effect; suicidality in young adults |
| 26 |
Insulin (Regular) |
Short-acting Insulin |
Hyperglycemia, Type 1 & 2 DM |
Only IV-compatible insulin; monitor glucose; peak 2–4 hrs; hypoglycemia risk |
| 27 |
Insulin Glargine (Lantus) |
Long-acting Insulin (Basal) |
Type 1 & 2 DM |
Once daily at same time; no peak; do NOT mix; monitor for hypoglycemia |
| 28 |
Metformin |
Biguanide (Oral Hypoglycemic) |
Type 2 Diabetes |
Hold before contrast/surgery; GI side effects; lactic acidosis risk; check eGFR |
| 29 |
Levothyroxine |
Thyroid Hormone Replacement |
Hypothyroidism |
Take on empty stomach; check TSH; tachycardia, weight loss = too high dose |
| 30 |
Hydrocortisone |
Corticosteroid |
Adrenal insufficiency, Inflammation |
Taper dose; immunosuppressant; monitor blood glucose, blood pressure |
| 31 |
Omeprazole (PPI) |
Proton Pump Inhibitor |
GERD, Peptic Ulcer |
Give 30–60 min before meals; long-term use: Mg2+ & B12 deficiency |
| 32 |
Ranitidine/Famotidine |
H2 Blocker |
GERD, Peptic Ulcer |
Onset in 1 hr; less effective than PPIs; monitor LFTs |
| 33 |
Ondansetron (Zofran) |
5-HT3 Antagonist (Antiemetic) |
Nausea & vomiting |
Monitor QTc; constipation; serotonin syndrome in high doses |
| 34 |
Metoclopramide |
Prokinetic / Antiemetic |
GERD, Gastroparesis, N&V |
Tardive dyskinesia with long-term use; EPS risk; monitor bowel sounds |
| 35 |
Lactulose |
Osmotic Laxative |
Constipation, Hepatic encephalopathy |
Monitor for electrolyte imbalance; titrate to 2–3 stools/day; cramping common |
| 36 |
Amoxicillin |
Penicillin Antibiotic |
Bacterial infections, H. pylori |
Ask about penicillin allergy; complete full course; rash alert |
| 37 |
Ciprofloxacin |
Fluoroquinolone Antibiotic |
UTI, Pneumonia, GI infections |
Avoid in children; tendon rupture risk; monitor QTc; take with water |
| 38 |
Azithromycin |
Macrolide Antibiotic |
Respiratory infections, STIs |
Monitor QTc; GI upset; drug interactions via CYP450 |
| 39 |
Vancomycin |
Glycopeptide Antibiotic |
MRSA, C. diff (oral) |
Monitor trough levels (10–20 mg/L); Red Man Syndrome (infuse slowly); nephrotoxicity |
| 40 |
Metronidazole (Flagyl) |
Nitroimidazole Antibiotic |
Anaerobic infections, C. diff, BV |
No alcohol (disulfiram reaction); metallic taste; take with food |
| 41 |
Clindamycin |
Lincosamide Antibiotic |
Skin infections, Anaerobes |
C. diff risk; monitor GI; complete full course |
| 42 |
Doxycycline |
Tetracycline Antibiotic |
Pneumonia, Malaria, Lyme disease |
Avoid in pregnancy/children <8; photosensitivity; take upright with water |
| 43 |
Piperacillin-Tazobactam |
Beta-lactam + Beta-lactamase inhibitor |
Severe gram-negative infections |
Monitor renal function & LFTs; allergy check; infuse over 3–4 hrs (extended) |
| 44 |
Ceftriaxone |
3rd Gen Cephalosporin |
Pneumonia, Meningitis, Gonorrhea |
Cross-reactivity with PCN allergy (~1%); do not mix with calcium-containing solutions |
| 45 |
Gentamicin |
Aminoglycoside Antibiotic |
Gram-negative sepsis |
Monitor drug levels (peak & trough); nephrotoxicity + ototoxicity; hydrate well |
| 46 |
Fluconazole |
Azole Antifungal |
Candidiasis, Cryptococcal meningitis |
Monitor LFTs; many CYP450 drug interactions; check for QTc prolongation |
| 47 |
Acyclovir |
Antiviral (Nucleoside Analogue) |
Herpes simplex, Varicella-Zoster |
Adequate hydration (renal stones risk); monitor BUN/Creatinine; IV: slow infusion |
| 48 |
Enoxaparin (LMWH) |
Low Molecular Weight Heparin |
DVT prophylaxis & treatment, ACS |
SQ injection; monitor anti-Xa level; antidote: Protamine (partial); check renal fn |
| 49 |
Rivaroxaban (Xarelto) |
Factor Xa Inhibitor (NOAC) |
DVT, PE, A-fib |
No routine monitoring; watch for bleeding; no specific antidote; take with food |
| 50 |
Alteplase (tPA) |
Thrombolytic |
Ischemic stroke (within 4.5 hrs), STEMI |
Strict eligibility criteria; monitor for intracranial hemorrhage; no antiplatelets x24hrs |
| 51 |
Lithium |
Mood Stabilizer |
Bipolar disorder |
Narrow therapeutic index (0.6–1.2 mEq/L); monitor levels, renal fn, thyroid; toxicity = tremors, confusion |
| 52 |
Fluoxetine (Prozac) |
SSRI |
Depression, OCD, Bulimia |
Long half-life; serotonin syndrome risk; suicidality; 4–6 wks for effect |
| 53 |
Quetiapine (Seroquel) |
Atypical Antipsychotic |
Schizophrenia, Bipolar, Insomnia (off-label) |
Sedation, metabolic syndrome, QTc prolongation; orthostatic hypotension |
| 54 |
Lorazepam (Ativan) |
Benzodiazepine |
Anxiety, Seizures, Alcohol withdrawal |
Respiratory depression; fall risk; dependence; antidote: Flumazenil |
| 55 |
Diazepam (Valium) |
Benzodiazepine |
Anxiety, Muscle spasm, Seizures |
Long-acting (active metabolites); sedation; respiratory depression; monitor closely |
| 56 |
Methotrexate |
Antimetabolite / DMARD |
Rheumatoid arthritis, Leukemia, Psoriasis |
Monitor CBC & LFTs; folic acid supplementation; teratogenic; mucositis |
| 57 |
Cyclophosphamide |
Alkylating Agent (Chemo) |
Cancer, Autoimmune disorders |
Hemorrhagic cystitis (hydrate well, Mesna); myelosuppression; monitor CBC |
| 58 |
Dexamethasone |
Corticosteroid |
Inflammation, Cerebral edema, Chemo nausea |
Monitor glucose, BP, infection risk; taper; not for long-term use |
| 59 |
Epoetin Alfa (EPO) |
Erythropoiesis-Stimulating Agent |
Anemia (CKD, Chemo-induced) |
Monitor Hgb (target 10–12 g/dL); BP elevation; thrombosis risk; IV/SC |
| 60 |
Ferrous Sulfate |
Iron Supplement |
Iron Deficiency Anemia |
Dark stools (normal); constipation; take on empty stomach; OJ enhances absorption |
| 61 |
Potassium Chloride (KCl) |
Electrolyte Replacement |
Hypokalemia |
NEVER IV push (cardiac arrest); dilute and infuse slowly; monitor EKG; irritating to veins |
| 62 |
Sodium Bicarbonate |
Alkalizing Agent / Electrolyte |
Metabolic acidosis, Hyperkalemia |
Monitor ABGs, electrolytes; avoid overload; can cause alkalosis |
| 63 |
Mannitol |
Osmotic Diuretic |
Increased ICP, Acute renal failure |
Monitor ICP, serum osmolality, I&O; do NOT use in HF; crystallization check |
| 64 |
Spironolactone |
Potassium-Sparing Diuretic |
Heart failure, Hyperaldosteronism |
Monitor K+ (hyperkalemia risk); avoid NSAIDs; gynecomastia in men |
| 65 |
Ketorolac (Toradol) |
NSAID (Injectable) |
Acute moderate-to-severe pain |
Max 5 days IV/IM; monitor renal fn & GI bleeding; assess pain relief |
| 66 |
Gabapentin |
Anticonvulsant / Neuropathic agent |
Neuropathic pain, Seizures |
Renal dosing; sedation, dizziness; fall risk; do not abruptly stop |
| 67 |
Cyclobenzaprine |
Skeletal Muscle Relaxant |
Muscle spasm |
Sedation; anticholinergic effects; avoid in elderly (Beers Criteria) |
| 68 |
Oxytocin (Pitocin) |
Oxytocic / Uterotonic |
Labor induction, Postpartum hemorrhage |
Continuous fetal monitoring; uterine hyperstimulation risk; titrate carefully |
| 69 |
Magnesium Sulfate |
Anticonvulsant / Tocolytic |
Pre-eclampsia/Eclampsia, Preterm labor |
Monitor RR (hold if <12), DTRs, urine output; antidote: Calcium gluconate |
| 70 |
Misoprostol |
Prostaglandin Analogue |
Cervical ripening, PPH prevention |
Monitor uterine contractions; GI side effects; avoid in prior C-section |
| 71 |
Naloxone (Narcan) |
Opioid Antagonist |
Opioid overdose reversal |
Short duration (re-dose may be needed); monitor RR; manage withdrawal symptoms |
| 72 |
Flumazenil |
Benzodiazepine Antagonist |
Benzodiazepine overdose reversal |
Short-acting (re-sedation risk); monitor CNS & RR; do NOT use in BZD-dependent patients |
| 73 |
Atropine |
Anticholinergic / Antidysrhythmic |
Bradycardia, Organophosphate poisoning |
Assess HR response; urinary retention; dry mouth; tachycardia at high doses |
| 74 |
Epinephrine (Adrenaline) |
Sympathomimetic (Catecholamine) |
Anaphylaxis, Cardiac arrest, Asthma |
IM for anaphylaxis (outer thigh); monitor HR/BP; assess response quickly |
| 75 |
Dopamine |
Vasopressor / Inotrope |
Shock, Severe hypotension |
Dose-dependent effects; titrate to BP/UO; monitor EKG; extravasation risk (central line preferred) |
| 76 |
Norepinephrine (Levophed) |
Vasopressor |
Septic shock, Severe hypotension |
Use central line; monitor MAP (target >65 mmHg); assess peripheral perfusion |
| 77 |
Amiodarone |
Class III Antiarrhythmic |
V-fib, V-tach, A-fib |
Pulmonary/thyroid/hepatic toxicity; monitor TFTs & LFTs; photosensitivity; QTc monitoring |
| 78 |
Adenosine |
Antiarrhythmic (Purine Nucleoside) |
SVT (PSVT) |
Rapid IV push + saline flush; brief asystole (warn patient); monitor EKG |
| 79 |
Calcium Gluconate |
Electrolyte / Antidote |
Hypocalcemia, Hypermagnesemia antidote |
Slow IV push; monitor EKG & serum calcium; antidote for Mag toxicity |
| 80 |
Dextrose 50% (D50) |
Glucose / Carbohydrate Solution |
Severe hypoglycemia |
IV push; monitor blood glucose post-administration; vesicant (extravasation risk) |
| 81 |
Losartan |
Angiotensin Receptor Blocker (ARB) |
Hypertension, Diabetic nephropathy |
Monitor BMP (hyperkalemia, renal fn); no cough (unlike ACE-I); teratogenic |
| 82 |
Carvedilol |
Alpha & Beta-Blocker |
Heart failure, Hypertension |
Monitor HR and BP; orthostatic hypotension; do not abruptly stop |
| 83 |
Hydralazine |
Direct Vasodilator |
Hypertensive emergency, Pregnancy HTN |
Reflex tachycardia; lupus-like syndrome (long-term); monitor BP closely |
| 84 |
Labetalol |
Alpha & Beta-Blocker |
Hypertensive emergency, Pregnancy |
BP monitoring every 5 min IV; do not use in asthma; monitor HR |
| 85 |
Trimethoprim-Sulfamethoxazole |
Sulfonamide Antibiotic (TMP-SMX) |
UTI, PCP pneumonia, MRSA |
Hydrate well; Stevens-Johnson risk; monitor CBC & renal fn; folate antagonist |
| 86 |
Linezolid |
Oxazolidinone Antibiotic |
VRE, MRSA |
Serotonin syndrome risk; monitor CBC (thrombocytopenia); no tyramine-rich foods |
| 87 |
Donepezil |
Acetylcholinesterase Inhibitor |
Alzheimer’s disease |
GI side effects; bradycardia; nightmares (take in AM if sleep disturbance) |
| 88 |
Methylphenidate (Ritalin) |
CNS Stimulant |
ADHD, Narcolepsy |
Monitor HR, BP, growth (children); insomnia; appetite suppression; abuse potential |
| 89 |
Naltrexone |
Opioid Antagonist (Long-acting) |
Opioid & Alcohol use disorder |
Opioid-free for 7–10 days before starting; liver toxicity; monitor LFTs |
| 90 |
Buprenorphine/Naloxone |
Partial Opioid Agonist (MOUD) |
Opioid use disorder |
Sublingual; precipitated withdrawal if given too soon; monitor for CNS depression |
| 91 |
Ipratropium |
Short-acting Anticholinergic (SAMA) |
COPD, Acute asthma (combination) |
Not for acute bronchospasm alone; avoid in glaucoma; dry mouth, urinary retention |
| 92 |
Salmeterol/Formoterol |
Long-Acting Beta-2 Agonist (LABA) |
Asthma maintenance, COPD |
Never use as rescue inhaler (fatal risk); only with ICS in asthma; palpitations |
| 93 |
Filgrastim (G-CSF) |
Granulocyte Colony-Stimulating Factor |
Chemo-induced neutropenia |
Bone pain; monitor CBC; discontinue when ANC recovers; inject SQ |
| 94 |
Dalteparin |
Low Molecular Weight Heparin |
DVT prophylaxis in cancer patients |
SQ injection; monitor for bleeding; no routine aPTT monitoring; anti-Xa if needed |
| 95 |
Glipizide |
Sulfonylurea (Oral Hypoglycemic) |
Type 2 Diabetes |
Hypoglycemia risk especially if meals skipped; photosensitivity; take 30 min before meals |
| 96 |
Sitagliptin (Januvia) |
DPP-4 Inhibitor |
Type 2 Diabetes |
Low hypoglycemia risk alone; pancreatitis risk; monitor renal fn for dosing |
| 97 |
Folic Acid |
Water-Soluble Vitamin B9 |
Megaloblastic anemia, Pregnancy prevention of NTDs |
Important in first trimester; monitor CBC; give with methotrexate therapy |
| 98 |
Cyanocobalamin (Vit B12) |
Water-Soluble Vitamin |
B12 Deficiency, Pernicious anemia |
IM route for pernicious anemia (intrinsic factor absent); monitor CBC & neuro symptoms |
| 99 |
Desmopressin (DDAVP) |
Synthetic ADH (Vasopressin Analogue) |
Diabetes insipidus, von Willebrand disease, Enuresis |
Monitor serum sodium (hyponatremia risk); fluid restriction; weigh daily |
| 100 |
Allopurinol |
Xanthine Oxidase Inhibitor |
Gout, Hyperuricemia (chemo) |
Increase fluid intake; monitor uric acid & renal fn; start after acute attack resolves |